ДЕСЯТИЛЕТНИЙ ОПЫТ ПРИМЕНЕНИЯ ТРАНСБРОНХИАЛЬНОЙ ЭНДОСОНОГРАФИИ В ОДНОМ ЦЕНТРЕ. / Vasilev, Igor V.; Zaitcev, Ivan A.; Kudriashov, Grigory G.; Lee, Vladimir F.; Novitskaya, Tatiana A.; Sokolovich, Evgeny G.; Yablonskiy, Petr K.
In: Инновационная медицина Кубани, No. 2, 20.06.2021, p. 6-13.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - ДЕСЯТИЛЕТНИЙ ОПЫТ ПРИМЕНЕНИЯ ТРАНСБРОНХИАЛЬНОЙ ЭНДОСОНОГРАФИИ В ОДНОМ ЦЕНТРЕ
AU - Vasilev, Igor V.
AU - Zaitcev, Ivan A.
AU - Kudriashov, Grigory G.
AU - Lee, Vladimir F.
AU - Novitskaya, Tatiana A.
AU - Sokolovich, Evgeny G.
AU - Yablonskiy, Petr K.
N1 - Васильев И.В., Зайцев И.А., Кудряшов Г.Г., Ли В.Ф., Новицкая Т.А., Соколович Е.Г., Яблонский П.К. Десятилетний опыт применения трансбронхиальной эндосонографии в одном центре. Инновационная медицина Кубани. 2021;(2):6-13. https://doi.org/10.35401/2500-0268-2021-22-2-6-13 Vasilev I.V., Zaitcev I.A., Kudriashov G.G., Lee V.F., Novitskaya T.A., Sokolovich E.G., Yablonskiy P.K. Ten-year experience of transbronchial endosonography in single center. Innovative Medicine of Kuban. 2021;(2):6-13. (In Russ.) https://doi.org/10.35401/2500-0268-2021-22-2-6-13
PY - 2021/6/20
Y1 - 2021/6/20
N2 - Transbronchial endosonography (EBUS) is a relatively new method for diagnosing of the pathological condition of the thoracic organs. Objective Analysis of 10 years of our experience in the use of transbronchial endosonography in a specialized center. Material and Methods During the period from April 2010 to April 2020, 756 transbronchial endosonographies were conducted on 756 patients. The studies were carried out for various indications: 1) Group 1 (483) – transbronchial puncture of the lymph nodes in order to obtain morphological confirmation of the etiology; 2) Group 2 (260) – staging of suspected or verified lung cancer to determine the descriptor N; 3) Group 3 (13) – a study that ended only with obtaining an endosonographic image. All patients underwent transbronchial endosonography using the special ultrasound bronchoscope EB-1970UK (Pentax Corp.) and the ultrasound scanner EUB 5000 Plus G OB/GYN – Vascular Ultrasound (HITACHI Corp.). Results General information content was 78%; verification of mediastinal lymphadenopathy was 72% (57, 79, 58% for smears, cytoblocks and smears + cytoblocks, cytoblocks vs smears + cytoblocks, p < 0.05). Verification of local changes in the mediastinum – 66%; verification of peribronchial tumor – 87%. Lung cancer staging – 87% (82, 88, 86% for smears, cytoblocks vs smears + cytoblocks, respectively, р > 0.05) Conclusion Тhe diagnostic utility of EBUS for the verification of mediastinal lymphadenopathy can range from 37,5 to 83% and rise with increasing experience for all persons involved. The use of cytoblocks showed the best results. The diagnostic utility of staging varies from 60 to 100% and does not depend on the method of processing the aspiration material.
AB - Transbronchial endosonography (EBUS) is a relatively new method for diagnosing of the pathological condition of the thoracic organs. Objective Analysis of 10 years of our experience in the use of transbronchial endosonography in a specialized center. Material and Methods During the period from April 2010 to April 2020, 756 transbronchial endosonographies were conducted on 756 patients. The studies were carried out for various indications: 1) Group 1 (483) – transbronchial puncture of the lymph nodes in order to obtain morphological confirmation of the etiology; 2) Group 2 (260) – staging of suspected or verified lung cancer to determine the descriptor N; 3) Group 3 (13) – a study that ended only with obtaining an endosonographic image. All patients underwent transbronchial endosonography using the special ultrasound bronchoscope EB-1970UK (Pentax Corp.) and the ultrasound scanner EUB 5000 Plus G OB/GYN – Vascular Ultrasound (HITACHI Corp.). Results General information content was 78%; verification of mediastinal lymphadenopathy was 72% (57, 79, 58% for smears, cytoblocks and smears + cytoblocks, cytoblocks vs smears + cytoblocks, p < 0.05). Verification of local changes in the mediastinum – 66%; verification of peribronchial tumor – 87%. Lung cancer staging – 87% (82, 88, 86% for smears, cytoblocks vs smears + cytoblocks, respectively, р > 0.05) Conclusion Тhe diagnostic utility of EBUS for the verification of mediastinal lymphadenopathy can range from 37,5 to 83% and rise with increasing experience for all persons involved. The use of cytoblocks showed the best results. The diagnostic utility of staging varies from 60 to 100% and does not depend on the method of processing the aspiration material.
KW - трансбронхиальная эндосонография, лимфоаденопатия средостения, инвазивное стадирование, саркоидоз, НМКРЛ, ЭБУС/ТАБ
UR - http://www.scopus.com/inward/record.url?scp=85109322083&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/80b68c36-2628-3958-a79a-543bf71cae31/
U2 - 10.35401/2500-0268-2021-22-2-6-13
DO - 10.35401/2500-0268-2021-22-2-6-13
M3 - статья
AN - SCOPUS:85109322083
SP - 6
EP - 13
JO - Инновационная медицина Кубани
JF - Инновационная медицина Кубани
SN - 2541-9897
IS - 2
ER -
ID: 78363475